MedPath

Prospective multicenter clinical study of Luqi Decoction in the treatment of chronic heart failure (stage C)

Phase 1
Not yet recruiting
Conditions
chronic heart failure
Registration Number
ITMCTR2000003716
Lead Sponsor
Shuguang Hospital Affiliated to Shanghai University of traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) According to the diagnostic criteria of stage C of heart failure;
(2) The age is over 18 years old, male and female are not limited;
(3) The clinical observation data were collected completely;
(4) The subjects agreed to test the relevant clinical indicators.

Exclusion Criteria

(1) Patients with definite multi system infection, tumor, connective tissue disease, autoimmune disease, recent operation or trauma;
(2) Moderate to severe dementia or mental illness can not cooperate with follow-up investigation;
(3) Pregnant and lactating women;
(4) The patients died in the acute phase.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.